{
  "title": "Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil",
  "link": "https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/",
  "dc:creator": "Ramisa Tasnim",
  "pubDate": "Wed, 03 Aug 2022 15:09:00 +0000",
  "guid": "https://www.reutersagency.com/en/?post_type=best&#038;p=293494",
  "description": "<p>Reuters exclusively reported UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit [&#8230;]</p>\n<p>The post <a rel=\"nofollow\" href=\"https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/\">Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil</a> appeared first on <a rel=\"nofollow\" href=\"https://www.reutersagency.com/en/\">Reuters News Agency</a>.</p>\n",
  "content:encoded": "\n<p>Reuters <a target=\"_blank\" href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-unitedhealth-struggling-sell-brazilian-unit-amil-2022-08-03/?elqTrackId=BCF2410E6A3775AAA6C3949BD4A7C494&elqTrack=true\" rel=\"noreferrer noopener\">exclusively reported</a> UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, asking for anonymity because the discussions were private.</p>\n<p>The post <a rel=\"nofollow\" href=\"https://www.reutersagency.com/en/reutersbest/article/reuters-reveals-unitedhealth-struggling-to-sell-brazilian-unit-amil/\">Reuters reveals UnitedHealth struggling to sell Brazilian unit Amil</a> appeared first on <a rel=\"nofollow\" href=\"https://www.reutersagency.com/en/\">Reuters News Agency</a>.</p>\n"
}